Healio: Driver training software program associated with fewer distractions in ADHD youth
Healio highlighted a recent trial published by University of Cincinnati and Cincinnati Children's Hospital Medical Center researchers that found a driver training software program reduced how often adolescent drivers with ADHD took long glances away from the roadway.
Led by Jeffery N. Epstein, PhD, professor in UC's Department of Pediatrics in the College of Medicine, director of the Cincinnati Children's Center for ADHD and a pediatric psychologist, the research was published in the New England Journal of Medicine.
Teenage drivers with ADHD are twice as likely than neurotypical teens to be in an accident, the researchers wrote, noting a struggle for these teens to sustain visual attention while driving.
In the trial, the researchers evaluated the effectiveness of an enhanced version of the Focused Concentration and Attention Learning (FOCAL+) program, a desktop-based software program that features multiple sessions and simulator training "with immediate auditory feedback" designed to reduce long glances away from the road of 2 seconds or longer.
The teen drivers with ADHD randomly assigned to the FOCAL+ program were found to have significantly fewer long glances from the roadway.
Featured photo at top courtesy of Unsplash.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
UC awarded nearly $1 million to help fight infant obesity spike
December 12, 2025
University of Cincinnati researcher Cathy Stough spoke with Spectrum News1 about a nearly $1 million National Institutes of Health grant awarded to UC to help prevent infant obesity through early nutrition support and family-based interventions.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.